UTMD vs. SPY
Compare and contrast key facts about Utah Medical Products, Inc. (UTMD) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTMD or SPY.
Key characteristics
UTMD | SPY | |
---|---|---|
YTD Return | -20.97% | 23.68% |
1Y Return | -19.72% | 37.19% |
3Y Return (Ann) | -7.92% | 10.85% |
5Y Return (Ann) | -5.74% | 16.16% |
10Y Return (Ann) | 4.03% | 13.85% |
Sharpe Ratio | -0.88 | 2.85 |
Sortino Ratio | -1.25 | 3.80 |
Omega Ratio | 0.86 | 1.52 |
Calmar Ratio | -0.46 | 3.03 |
Martin Ratio | -1.21 | 18.48 |
Ulcer Index | 17.18% | 1.91% |
Daily Std Dev | 23.74% | 12.40% |
Max Drawdown | -76.72% | -55.19% |
Current Drawdown | -44.19% | -0.34% |
Correlation
The correlation between UTMD and SPY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
UTMD vs. SPY - Performance Comparison
In the year-to-date period, UTMD achieves a -20.97% return, which is significantly lower than SPY's 23.68% return. Over the past 10 years, UTMD has underperformed SPY with an annualized return of 4.03%, while SPY has yielded a comparatively higher 13.85% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTMD vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UTMD vs. SPY - Dividend Comparison
UTMD's dividend yield for the trailing twelve months is around 1.83%, more than SPY's 1.20% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Utah Medical Products, Inc. | 1.83% | 1.41% | 1.16% | 2.84% | 1.31% | 1.01% | 1.28% | 1.28% | 1.41% | 1.72% | 1.64% | 1.69% |
SPDR S&P 500 ETF | 1.20% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
UTMD vs. SPY - Drawdown Comparison
The maximum UTMD drawdown since its inception was -76.72%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for UTMD and SPY. For additional features, visit the drawdowns tool.
Volatility
UTMD vs. SPY - Volatility Comparison
Utah Medical Products, Inc. (UTMD) has a higher volatility of 3.44% compared to SPDR S&P 500 ETF (SPY) at 2.96%. This indicates that UTMD's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.